Nuveen, LLC Vera Therapeutics, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 156,882 shares of VERA stock, worth $4.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
156,882Holding current value
$4.01 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
191Shares Held
62.7MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$143 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$112 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$85.2 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$75.6 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$74.5 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $690M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...